Ovid Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | BuyUS$50,364 | Jeremy Levin | Individual | 18,248 | US$2.76 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 3,701,655 | 5.21% |
Public Companies | 7,531,996 | 10.6% |
Hedge Funds | 13,286,560 | 18.7% |
General Public | 20,974,296 | 29.5% |
Institutions | 25,515,359 | 35.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,531,996 | US$7.8m | 0% | no data | |||
5,315,969 | US$5.5m | 0% | 0.09% | |||
4,116,773 | US$4.3m | 0.85% | 0.31% | |||
3,992,346 | US$4.2m | 0% | no data | |||
3,853,818 | US$4.0m | 0% | 0.12% | |||
3,652,196 | US$3.8m | 0% | no data | |||
3,142,439 | US$3.3m | 1.72% | no data | |||
2,850,000 | US$3.0m | 0% | 0.14% | |||
1,847,334 | US$1.9m | 11% | no data | |||
1,527,985 | US$1.6m | 2.65% | 0.03% | |||
1,400,191 | US$1.5m | 0% | 0.01% | |||
1,361,455 | US$1.4m | 0.52% | no data | |||
1,317,330 | US$1.4m | 1.14% | no data | |||
1,315,585 | US$1.4m | -1% | no data | |||
771,531 | US$802.4k | -31.4% | 1.81% | |||
729,208 | US$758.4k | -32.2% | 0.2% | |||
717,046 | US$745.7k | -0.79% | no data | |||
628,290 | US$653.4k | 118% | 0.06% | |||
480,225 | US$499.4k | 3.16% | no data | |||
454,880 | US$473.1k | -7.19% | 0.01% | |||
260,509 | US$270.9k | 118% | 0.02% | |||
250,000 | US$260.0k | 0% | 0.19% | |||
220,401 | US$229.2k | 4,130% | no data | |||
165,763 | US$172.4k | -24% | no data | |||
163,614 | US$170.2k | 147% | no data |